Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-26-012539
Filing Date
2026-02-26
Accepted
2026-02-26 20:39:05
Documents
1
Period of Report
2026-02-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1772156343.html 4  
1 FORM 4 wk-form4_1772156343.xml 4 3467
  Complete submission text file 0001628280-26-012539.txt   4886
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Issuer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL CA 94901
Business Address
Friberg Gregory R (Reporting) CIK: 0002038768 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26727 | Film No.: 26691855